Stay updated on Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Recruitment status updated to no longer recruit participants, signaling the study has stopped enrolling. The page also adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the site revision to v3.6.0, with minor header formatting adjustments to Intervention/Treatment.
    Difference
    0.2%
    Check dated 2026-06-10T12:48:23.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page version has been bumped from v3.5.4 to v3.5.5, indicating a minor update to the page. This change does not appear to affect study data or patient-facing information.
    Difference
    0.0%
    Check dated 2026-06-03T05:48:02.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new publication citation has been added to the Publications section, referencing a 2026 article about Lenvatinib plus Pembrolizumab outcomes in advanced or recurrent endometrial cancer (KEYNOTE-775/LEAP-001). The entry documents post-(neo)adjuvant therapy outcomes related to the study.
    Difference
    0.0%
    Check dated 2026-05-27T01:21:35.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a newer version of the page content. This update is a metadata version change and does not modify substantive study details.
    Difference
    0.0%
    Check dated 2026-05-19T23:40:14.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The Taiwan study site entry was updated from Taoyuan District, Taiwan, 33305 to Taoyuan, Taiwan, 33305. The postal code remains the same, but the city designation is clarified to Taoyuan.
    Difference
    0.0%
    Check dated 2026-05-05T12:48:11.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.5.3 has been added, replacing Revision: v3.5.2. This indicates a minor site update that does not affect page content or functionality.
    Difference
    0.0%
    Check dated 2026-04-28T07:51:25.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.